medscape.com

Europe following Switzerland on psychedelic policy and care models. The coverage centers on how Swiss approaches have influenced broader European discussions, likely touching licensing, clinical pathways, and regulation for psychedelic-assisted care. The piece frames psychedelics as part of mainstream medical development, connecting policy movement with ongoing clinical evidence and health-system implementation.